Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients.
Kumar, D; Ferreira, V H; Campbell, P; Hoschler, K; Humar, A.
Am J Transplant
; 17(1): 281-286, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27402204
Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients.
Outbreak of Influenza A(H1N1) in a Kidney Transplant Unit-Protective Effect of Vaccination.
Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients.
Influenza and End-Stage Renal Disease: A Fatal Combination.
Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients.
Similar clinical results of influenza vaccination in peritoneal dialysis and haemodialysis patients.
Seasonal influenza vaccination is associated with reduced morbidity and mortality in peritoneal dialysis patients.
Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.
Broadly neutralizing antiviral antibodies.
Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety.